Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Rivastigmine 2mg/ml oral solution |
| BNF code | 0411000E0AAAHAH |
| Virtual Therapeutic Moiety | Rivastigmine |
| Date identifier became valid | 7 Jul 2023 |
| Previous product identifier | 408624008 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products not Available |
| Non-availability status date | 11 Apr 2018 |
| Dose form | Continuous |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Rivastigmine hydrogen tartrate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 395868008 |
| Strength value numerator | 2.000 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | solution.oral |
| Dose Form | |
| Formulation | Oral solution |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Virtual Medicinal Product Packs | |
| Rivastigmine 2mg/ml oral solution 120 ml | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.